-
Posted by
Two Blokes Thu at 2:30 PM -
Filed in
Stock
-
0 views
Phathom Pharmaceuticals, Inc. (PHAT) came out with a quarterly loss of $1.07 per share versus the Zacks Consensus Estimate of a loss of $1.06. This compares to loss of $1.42 per share a year ago.
